Your browser doesn't support javascript.
loading
Multiomic Characterization of High-Grade Serous Ovarian Carcinoma Enables High-Resolution Patient Stratification.
Hollis, Robert L; Meynert, Alison M; Michie, Caroline O; Rye, Tzyvia; Churchman, Michael; Hallas-Potts, Amelia; Croy, Ian; McCluggage, W Glenn; Williams, Alistair R W; Bartos, Clare; Iida, Yasushi; Okamoto, Aikou; Dougherty, Brian; Barrett, J Carl; March, Ruth; Matakidou, Athena; Roxburgh, Patricia; Semple, Colin A; Harkin, D Paul; Kennedy, Richard; Herrington, C Simon; Gourley, Charlie.
Afiliación
  • Hollis RL; Nicola Murray Centre for Ovarian Cancer Research, Cancer Research UK Scotland Centre, Institute of Genetics and Cancer, University of Edinburgh, Edinburgh, UK.
  • Meynert AM; MRC Human Genetics Unit, Institute of Genetics and Cancer, University of Edinburgh, Edinburgh, UK.
  • Michie CO; Edinburgh Cancer Centre, Western General Hospital, NHS Lothian, Edinburgh, UK.
  • Rye T; Nicola Murray Centre for Ovarian Cancer Research, Cancer Research UK Scotland Centre, Institute of Genetics and Cancer, University of Edinburgh, Edinburgh, UK.
  • Churchman M; Nicola Murray Centre for Ovarian Cancer Research, Cancer Research UK Scotland Centre, Institute of Genetics and Cancer, University of Edinburgh, Edinburgh, UK.
  • Hallas-Potts A; Nicola Murray Centre for Ovarian Cancer Research, Cancer Research UK Scotland Centre, Institute of Genetics and Cancer, University of Edinburgh, Edinburgh, UK.
  • Croy I; Nicola Murray Centre for Ovarian Cancer Research, Cancer Research UK Scotland Centre, Institute of Genetics and Cancer, University of Edinburgh, Edinburgh, UK.
  • McCluggage WG; Department of Pathology, Belfast Health and Social Care Trust, Belfast, UK.
  • Williams ARW; Division of Pathology, The Royal Infirmary of Edinburgh, Edinburgh, UK.
  • Bartos C; Nicola Murray Centre for Ovarian Cancer Research, Cancer Research UK Scotland Centre, Institute of Genetics and Cancer, University of Edinburgh, Edinburgh, UK.
  • Iida Y; Nicola Murray Centre for Ovarian Cancer Research, Cancer Research UK Scotland Centre, Institute of Genetics and Cancer, University of Edinburgh, Edinburgh, UK.
  • Okamoto A; The Jikei University School of Medicine, Tokyo, Japan.
  • Dougherty B; The Jikei University School of Medicine, Tokyo, Japan.
  • Barrett JC; Translational Medicine, Oncology R&D, AstraZeneca, Waltham, Massachusetts.
  • March R; Translational Medicine, Oncology R&D, AstraZeneca, Waltham, Massachusetts.
  • Matakidou A; Precision Medicine and Biosamples, Oncology R&D, AstraZeneca, Cambridge, UK.
  • Roxburgh P; Centre for Genomics Research, Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK.
  • Semple CA; Institute of Cancer Sciences, Wolfson Wohl Cancer Research Centre, University of Glasgow, Belfast, UK.
  • Harkin DP; Beatson West of Scotland Cancer Centre, Glasgow, UK.
  • Kennedy R; MRC Human Genetics Unit, Institute of Genetics and Cancer, University of Edinburgh, Edinburgh, UK.
  • Herrington CS; Almac Diagnostics, Craigavon, UK.
  • Gourley C; Centre for Cancer Research and Cell Biology, Queen's University Belfast, Belfast, UK.
Clin Cancer Res ; 28(16): 3546-3556, 2022 08 15.
Article en En | MEDLINE | ID: mdl-35696721
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias Ováricas / Cistadenocarcinoma Seroso Tipo de estudio: Prognostic_studies Límite: Female / Humans Idioma: En Revista: Clin Cancer Res Asunto de la revista: NEOPLASIAS Año: 2022 Tipo del documento: Article País de afiliación: Reino Unido
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias Ováricas / Cistadenocarcinoma Seroso Tipo de estudio: Prognostic_studies Límite: Female / Humans Idioma: En Revista: Clin Cancer Res Asunto de la revista: NEOPLASIAS Año: 2022 Tipo del documento: Article País de afiliación: Reino Unido